Virtus ETF Advisers’s Juno Therapeutics, Inc. JUNO Stock Holding History

Virtus ETF Advisers’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,860	Closed	-$359K	–	266
2017 Q4	$359K	Sell	7,860 -6,401	-45%	-$319K	0.45%	77
2017 Q3	$640K	Buy	14,261 +1,304	+10%	+$44.5K	0.09%	76
2017 Q2	$387K	Sell	12,957 -2,697	-17%	-$66.6K	0.06%	79
2017 Q1	$347K	Buy	15,654 +1,501	+11%	+$32.2K	0.06%	124
2016 Q4	$267K	Buy	14,153 +8,136	+135%	+$199K	0.08%	124
2016 Q3	$181K	Hold	6,017	–	–	0.09%	146
2016 Q2	$231K	Buy	6,017 +664	+12%	+$27.6K	0.17%	112
2016 Q1	$204K	Buy	+5,353	New	+$187K	0.28%	80

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Virtus ETF Advisers's JUNO Position: Q1 2018 in Review

Virtus ETF Advisers sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 7,860 shares — an estimated $359K sold.

Virtus ETF Advisers first reported a position in JUNO in Q1 2016 and held it in 8 quarters. The position peaked at $640K in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Virtus ETF Advisers reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Virtus ETF Advisers sold 7,860 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $359K.
Virtus ETF Advisers first reported a position in Juno Therapeutics, Inc. in Q1 2016 and held it in 8 quarters.
Virtus ETF Advisers's Juno Therapeutics, Inc. position peaked at $640K in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Virtus ETF Advisers's 13F filing for Q1 2018, filed 14 May 2018.